uPAR-PLAU complex binds Vtn and accelerates the cell adhesion and migration.
14,15
The main sources of Vtn and PLAU proteins are unclear in the ISR process. Previous studies showed that white blood cells, especially monocytes, increase after stent implantation. Also, the studies suggested that the monocyte accumulation in the stenting site correlates with VSMC proliferation and neointimal growth. 16 Thus, the aim of this study was to investigate the Vtn and PLAU gene expression levels in peripheral blood mononuclear cell (PBMC) samples isolated from patients with the ISR. It may explain the roles of these genes in the VSMC activation.
Methods Subjects
A total of 66 volunteers undergoing coronary artery angiography participated in the study. All samples were randomly selected from Shahid Rajaee Hospital, Tehran (2015 Tehran ( -2016 . The subjects were categorized into three groups: 22 healthy subjects (stenosis < 5%) and 44 patients with coronary artery stent implantation (stent no-restenosis [SNR], n ¼ 22; stenosis < 70% with ISR [ISR], n ¼ 22; restenosis > 70%). A medical interview was considered to have no clinical problems (metabolic diseases, myocardial infarction, and stroke). The University Ethics Committee has approved the study, and an informed consent was obtained from all participants.
Sample
The whole-blood samples (10 mL) were collected in ethylenediaminetetraacetic acid vacationers and were transferred into the laboratory using special bags containing cold ice packs.
Peripheral Blood Mononuclear Cell Isolation
The blood sample was diluted with phosphate buffered saline (PBS; 1:1 ratio) and was added into Ficoll solution (3 mL; Sigma-Aldrich). Then, it was gently mixed and was centrifuged for 30 minutes at 400 Â g. The PBMC layer was separated from the other layers consisting of red blood cells, granulocytes, and plasma. Afterward, it was washed and centrifuged with PBS (three times, each time for 10 minutes at 200 Â g).
Ribonucleic Acid Extraction
Total ribonucleic acid (RNA) was prepared from the PBMC sample (RNA extraction kit, GeneMark, Georgia Institute of Technology, Atlanta, GA) according to the manufacturer's instruction. The RNA concentration was calculated by 
Complementary Deoxyribonucleic Acid Synthesis
Complementary deoxyribonucleic acid (cDNA) was synthesized with the cDNA Synthesis kit (Prime Script II strand cDNA Synthesis Kit, Takara, Japan) according to the manufacturer's instructions.
Real-Time Quantitative Polymerase Chain Reaction Technique
The Vtn and PLAU gene expression levels were measured by SYBR Green Real-Time qPCR technique (RG-6000 RotorGene, Corbett Research, Sydney, Australia) and were normalized with the actin-β gene. The amplification reaction was performed in a volume (10 μL) containing forward and reverse primers (0.5 μm) and cDNA sample (1 μL). The amplification cycles (n ¼ 40) were performed at 95°C for 10 seconds and at 59°C for 30 seconds. The primers were designed with the Primer-blast tool (►Table 1).
Statistical Analysis
The data were collected using a questionnaire. Statistical analyses were performed using statistical software package (SPSS, version 18.0, SPSS Inc., Chicago, IL 
Urokinase-Type Plasminogen Activator Gene Expression
The PLAU gene expression level increased in the patients with coronary artery stent implantation. ►Fig. 1 shows that the PLAU gene expression elevates up to 27-folds in patients with coronary ISR (p < 0001). Furthermore, the linear and multiple regression analyses showed that the PLAU gene expression levels are not correlated to lipid profile (►Table 3) and age/gender parameters (►Table 4).
Vitronectin Gene Expression
The Vtn gene expression level increased up to 17-folds in the patients with coronary ISR (p < 001) (►Fig. 2). However, the Vtn gene expression was not correlated to lipid profile (►Table 5). Also, the multiple regression analysis did not
show an association between Vtn gene expression levels and age/gender parameters (►Table 6).
Discussion
The coronary artery restenosis, known as vessel renarrowing, is a serious complication in patients undergoing PTCA. 17 The neointimal hyperplasia is the main cause for vessel renarrowing events. It usually occurs due to the proliferation of VSMCs and their migration into vessel endothelium. [3] [4] [5] [6] In this field, some studies reported a positive correlation between circulating monocytes and neointimal volume in the patients with ISR. It is proposed that some factors secreted from circulating monocytes may stimulate the VSMC proliferation and motility leading to neointimal hyperplasia. 18, 19 In normal states, the studies reported that the activated monocytes secrete numerous factors such as cytokines, metalloproteinases, and some compounds to stimulate the VSMCs. A bibliographic search predicted the extracellular monocyte proteins (n ¼ 71) involved in VSMC signaling pathways. The study proposed that the cytokine-cytokine receptor interaction, focal adhesion, and regulation of actin cytoskeleton pathways may be related to VSMC proliferation and migration. 20 The PLAU is one these proteins to be related to coronary artery restenosis. Some studies showed that the PLAU-uPAR complex is involved in the proteolytic processes following the tissue remodeling and cellular migration. 21 Moreover, it may activate latent growth factors. 22 The studies also reported that the active PLAU catalyzes highly specific the plasminogen into plasmin so that it promotes extracellular matrix degradation and matrix metalloproteinase (MMP) activation. 23 Therefore, the PLAU overexpression is expected to develop the restenosis after coronary artery stent implantation due to the increase of PLAU and uPAR interactions and the improvement of proteolytic events within extracellular space. On the other hand, uPAR may also interact with other proteins including Vtn. The RGD motif on Vtn is an interactive site to many adhesive macromolecules.
24 PAI-1 binds to the RGD region, thereby antagonizing the function of Vtn. Furthermore, the Vtn mediates the interaction of PLAU with integrins and promotes the cellular proliferation, migration, focal adhesion, and integrin-mediated pathways. 25 More evidences showed that the Vtn promotes the cellular migration by competing for the binding of PAI-1. Our results demonstrated the increase of the Vtn gene expression in the patients with ISR. These findings suggested that upon increasing of PLAU, Vtn, and uPAR interactions on the VSMC membrane, the restenosis process may be developed due to the VSMC migration into vessel endothelium in stenting site. 26, 27 Based on the roles of Vtn and PLAU in VSMC motility, we suggested that the PBMCs may be a main source for the secretion of factors that may simulate VSMC proliferation and migration in patients with ISR.
Conclusion
The results suggested that the PBMCs may be a main source for the secretion of PLAU and Vtn. The findings also proposed that the increase of these genes may promote the restenosis process. However, a need for more research may be appropriate. Vtn and PLAU in In-Stent Patients Shafiee et al. 221
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